DNLI Denali Therapeutics Inc.
Fundamentals / CIK 0001714899 / USDDenali Therapeutics Inc. reported $0 in revenue and a net loss of $314.4M for the fiscal year ended December 31, 2025.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DNLI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$0 Dec 31, 2025
-
Operating Income FY 2025-$532.0M Operating profit
-
Net Income FY 2025-$314.4M GAAP bottom line
-
Diluted EPS FY 2025-$1.64 Split-adjusted
-
Free Cash Flow FY 2025-$450.0M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$516.2M Total debt: $35.24M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $330.5M | $108.5M | $48.66M | $335.7M | $26.68M | $129.2M | $0 | $0 |
| Research & Development | $418.8M | $396.4M | $423.9M | $358.7M | $265.4M | $212.6M | $193.4M | $143.2M | $74.46M | $75.70M |
| Total Operating Expenses | $555.3M | $501.9M | $527.2M | $449.2M | $344.4M | $272.9M | $239.9M | $175.5M | $90.14M | $87.43M |
| Operating Income | -$555.3M | -$487.3M | -$196.7M | -$340.7M | -$295.8M | $62.72M | -$213.2M | -$46.37M | -$90.14M | -$87.43M |
| EBITDA | -$544.2M | -$479.5M | -$180.0M | -$330.4M | -$287.2M | $71.25M | -$205.2M | -$38.96M | -$87.06M | -$85.96M |
| Income Tax Expense | $102K | $68K | $30K | $21K | -$575K | $823K | -$351K | $0 | $0 | -- |
| Net Income | -$512.5M | -$422.8M | -$145.2M | -$326.0M | -$290.6M | $71.14M | -$197.6M | -$36.24M | -$88.19M | -$86.65M |
| Basic EPS | -$2.97 | -$2.57 | -$1.06 | -$2.60 | -$2.39 | $0.65 | -$2.07 | -$0.39 | -$5.89 | -$13.49 |
| Diluted EPS | -$2.97 | -$2.57 | -$1.06 | -$2.60 | -$2.39 | $0.63 | -$2.07 | -$0.39 | -$5.89 | -$13.49 |
| Basic Shares Outstanding | 172.6M | 164.5M | 137.4M | 125.5M | 121.5M | 109.0M | 95.6M | 92.6M | 15.0M | 6.4M |
| Diluted Shares Outstanding | 172.6M | 164.5M | 137.4M | 125.5M | 121.5M | 112.7M | 95.6M | 92.6M | 15.0M | 6.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.78M | $3.60M | -- | -- | $0 | $0 | -- | $0 |
| Cost of Revenue | $192K | $93K | -- | -- | $0 | $0 | -- | -- |
| Gross Profit | $17.59M | $3.51M | -- | -- | $0 | $0 | -- | -- |
| Research & Development | $106.1M | $97.02M | $103.8M | $97.91M | $102.0M | $102.7M | $116.2M | $99.79M |
| Selling, General & Admin | $37.48M | $36.28M | -- | -- | $35.48M | $32.27M | -- | -- |
| Total Operating Expenses | -- | -- | $137.4M | $137.4M | $137.4M | $135.0M | $145.6M | $129.8M |
| Operating Income | -$126.8M | -$130.5M | -$137.4M | -$137.4M | -$137.4M | -$135.0M | -$145.6M | -$129.8M |
| EBITDA | -$123.2M | -$127.0M | -$134.5M | -$134.5M | -$134.5M | -$131.9M | -$143.3M | -$128.0M |
| Net Income | $70.13M | -$127.6M | -$128.4M | -$128.5M | -$126.9M | -$124.1M | -$133.0M | -$114.8M |
| Basic EPS | $0.37 | -$0.68 | -$0.69 | -- | -$0.74 | -$0.72 | -$0.78 | -- |
| Diluted EPS | $0.37 | -$0.68 | -$0.69 | -- | -$0.74 | -$0.72 | -$0.78 | -- |
| Basic Shares Outstanding | 188.4M | 187.3M | 186.6M | -- | 172.4M | 171.4M | 171.2M | -- |
| Diluted Shares Outstanding | 192.1M | 187.3M | 186.6M | -- | 172.4M | 171.4M | 171.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $205.3M | $175.0M | $127.1M | $218.0M | $293.5M | $507.1M | $79.45M | $77.12M | $218.4M |
| Short-Term Investments | $662.6M | $657.4M | $907.4M | $1.12B | $571.9M | $962.6M | $335.9M | $387.2M | $187.9M |
| Cash & Short-Term Investments | $867.9M | $832.3M | $1.03B | $1.34B | $865.4M | $1.47B | $415.4M | $464.3M | $406.2M |
| Accounts Receivable, Net | $0 | -- | -- | -- | -- | $8.59M | -- | -- | -- |
| Inventory | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $900.7M | $864.4M | $1.06B | $1.37B | $897.2M | $1.50B | $430.0M | $480.8M | $409.6M |
| Property, Plant & Equipment, Net | $52.40M | $55.24M | $45.59M | $44.09M | $38.87M | $40.85M | $46.73M | $25.16M | $14.92M |
| Intangible Assets | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-Term Investments | $98.32M | $359.4M | $0 | $0 | $425.4M | $32.70M | $39.89M | $147.9M | $60.75M |
| Other Non-Current Assets | $25.94M | $24.74M | $18.14M | $13.40M | $11.87M | $2.46M | $2.66M | $8.11M | $1.44M |
| Total Non-Current Assets | $244.2M | $509.7M | $89.78M | $87.92M | $506.9M | $108.6M | $123.2M | $181.1M | $77.11M |
| Total Assets | $1.14B | $1.37B | $1.15B | $1.46B | $1.40B | $1.60B | $553.2M | $662.0M | $486.7M |
| Accounts Payable | $505K | $11.14M | $9.48M | $2.79M | $4.78M | $1.07M | $2.59M | $1.89M | $2.72M |
| Deferred Revenue (Current) | -- | -- | $0 | $290.1M | $27.91M | $19.91M | $18.74M | $11.43M | $0 |
| Other Current Liabilities | -- | -- | $0 | $4.39M | $53.16M | $47.15M | $24.02M | $19.47M | $63K |
| Total Current Liabilities | $98.35M | $102.2M | $77.98M | $363.9M | $378.2M | $71.70M | $45.34M | $32.79M | $14.16M |
| Deferred Revenue (Non-Current) | -- | -- | $0 | $479K | $3.40M | $23.32M | $43.75M | $57.35M | $0 |
| Other Non-Current Liabilities | -- | -- | $0 | $379K | $379K | $701K | $379K | $471K | $467K |
| Total Non-Current Liabilities | $32.74M | $42.29M | $44.98M | $53.89M | $63.63M | $382.1M | $113.0M | $82.35M | $6.76M |
| Total Liabilities | $131.1M | $144.5M | $123.0M | $417.8M | $441.9M | $453.7M | $158.3M | $115.1M | $20.93M |
| Total Debt (incl. Leases) | $42.29M | $54.32M | $52.24M | $60.35M | $64.01M | $68.86M | $72.53M | -- | -- |
| Common Stock | -- | -- | $1.71M | $1.69M | $1.55M | $1.53M | $1.29M | $1.27M | $1.20M |
| Retained Earnings | -$2.05B | -$1.54B | -$1.12B | -$971.0M | -$645.0M | -$354.4M | -$425.6M | -$227.9M | -$191.7M |
| Accumulated Other Comp. Income | $682K | $2.02M | $643K | -$6.89M | -$2.50M | -$245K | $350K | -$649K | -$368K |
| Total Stockholders' Equity | $1.01B | $1.23B | $1.03B | $1.04B | $962.3M | $1.15B | $394.9M | $546.8M | $465.8M |
| Total Equity | $1.01B | $1.23B | $1.03B | $1.04B | $962.3M | $1.15B | $394.9M | $546.8M | $465.8M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $102.9M | $201.5M | $387.6M | $205.3M | $90.96M | $141.2M | $56.95M | $175.0M |
| Short-Term Investments | $413.3M | $508.9M | $600.1M | $662.6M | $757.2M | $757.7M | $761.0M | $657.4M |
| Cash & Short-Term Investments | $516.2M | $710.5M | $987.7M | $867.9M | $848.2M | $899.0M | $817.9M | $832.3M |
| Accounts Receivable, Net | $18.88M | $3.93M | -- | $0 | -- | -- | -- | -- |
| Inventory | $26.27M | $4.14M | -- | $0 | -- | -- | -- | -- |
| Total Current Assets | $591.7M | $753.9M | $1.02B | $900.7M | $882.6M | $934.7M | $878.6M | $864.4M |
| Property, Plant & Equipment, Net | $47.91M | $49.93M | $51.73M | $52.40M | $53.73M | $58.72M | $57.77M | $55.24M |
| Intangible Assets | $34.50M | $35.25M | $36.00M | $0 | -- | -- | -- | -- |
| Long-Term Investments | $491.4M | $229.5M | $63.78M | $98.32M | $24.70M | $78.46M | $235.8M | $359.4M |
| Other Non-Current Assets | $29.15M | $25.82M | $26.22M | $25.94M | $25.11M | $22.97M | $26.93M | $24.74M |
| Total Non-Current Assets | $664.3M | $404.0M | $243.3M | $244.2M | $173.0M | $231.5M | $392.7M | $509.7M |
| Total Assets | $1.26B | $1.16B | $1.27B | $1.14B | $1.06B | $1.17B | $1.27B | $1.37B |
| Accounts Payable | $13.70M | $11.81M | $40.38M | $505K | $6.75M | $10.84M | $8.46M | $11.14M |
| Total Current Liabilities | $95.26M | $90.08M | $110.2M | $98.35M | $90.15M | $91.06M | $91.88M | $102.2M |
| Total Non-Current Liabilities | $234.4M | $232.7M | $229.8M | $32.74M | $39.28M | $48.13M | $56.78M | $42.29M |
| Total Liabilities | $329.6M | $322.8M | $339.9M | $131.1M | $129.4M | $139.2M | $148.7M | $144.5M |
| Total Debt (incl. Leases) | $35.24M | $37.69M | $40.05M | $42.29M | $44.48M | $47.97M | $51.57M | $54.32M |
| Retained Earnings | -$2.24B | -$2.31B | -$2.18B | -$2.05B | -$1.92B | -$1.80B | -$1.67B | -$1.54B |
| Accumulated Other Comp. Income | -$6.36M | -$1.97M | -$682K | $682K | $1.10M | $939K | $2.04M | $2.02M |
| Total Stockholders' Equity | $926.4M | $835.2M | $926.1M | $1.01B | $926.2M | $1.03B | $1.12B | $1.23B |
| Total Equity | $926.4M | $835.2M | $926.1M | $1.01B | $926.2M | $1.03B | $1.12B | $1.23B |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$512.5M | -$422.8M | -$145.2M | -$326.0M | -$290.6M | $71.14M | -$197.6M | -$36.24M | -$88.19M | -$86.65M |
| Depreciation & Amortization | $11.18M | $7.79M | $16.73M | $10.38M | $8.59M | $8.53M | $7.99M | $7.42M | $3.08M | $1.47M |
| Stock-Based Compensation | $99.63M | $102.9M | $108.1M | $99.85M | $85.25M | $50.35M | $38.38M | $18.79M | $4.41M | $2.95M |
| Change in Payables | -$7.52M | $1.44M | $2.43M | $2.27M | $3.71M | -$1.62M | $1.03M | -$526K | $207K | $161K |
| Operating Cash Flow | -$412.6M | -$347.7M | -$358.0M | -$244.7M | -$211.4M | $416.2M | -$151.6M | $50.12M | -$76.64M | -$71.91M |
| Capital Expenditure | -$9.50M | -$15.91M | -$12.94M | -$17.83M | -$8.50M | -$3.10M | -$17.92M | -$3.39M | -$2.88M | -$6.13M |
| Free Cash Flow | -$422.1M | -$363.6M | -$370.9M | -$262.5M | -$219.9M | $413.1M | -$169.5M | $46.72M | -$79.51M | -$78.04M |
| Purchases of Investments | -$441.3M | -$1.23B | -$1.81B | -$1.12B | -$1.42B | -$1.29B | -$369.7M | -$557.9M | -$179.8M | -$226.4M |
| Investing Cash Flow | $255.3M | -$88.76M | $249.3M | -$141.4M | -$21.63M | -$623.2M | $147.7M | -$287.4M | -$41.17M | -$219.0M |
| Common Stock Issued | -- | $0 | $0 | $296.2M | $0 | $193.9M | $0 | $0 | $265.6M | $0 |
| Financing Cash Flow | $189.2M | $484.3M | $17.82M | $310.7M | $19.35M | $634.7M | $6.19M | $97.02M | $296.3M | $300.5M |
| Net Change in Cash | $31.90M | $47.85M | -$90.86M | -$75.43M | -$213.7M | $427.7M | $2.33M | -$140.3M | $178.5M | $9.56M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $70.13M | -$127.6M | -$128.4M | -$128.5M | -$126.9M | -$124.1M | -$133.0M | -$114.8M |
| Depreciation & Amortization | $3.58M | $3.57M | $2.85M | $2.87M | $2.95M | $3.04M | $2.33M | $1.85M |
| Stock-Based Compensation | $22.86M | $22.91M | $23.09M | $23.95M | $25.14M | $25.39M | $25.16M | $25.08M |
| Change in Payables | $8.90M | $227K | $3.88M | -$3.41M | -$4.07M | $2.60M | -$2.64M | $1.29M |
| Operating Cash Flow | -$117.4M | -$97.00M | -$131.2M | -$98.54M | -$107.3M | -$75.30M | -$131.5M | -$83.72M |
| Capital Expenditure | -$1.01M | -$805K | -$2.47M | -$1.52M | $1.38M | -$4.28M | -$5.08M | -$5.09M |
| Free Cash Flow | -$118.5M | -$97.81M | -$133.7M | -$100.1M | -$105.9M | -$79.58M | -$136.5M | -$88.81M |
| Purchases of Investments | -$355.2M | -$271.5M | -$123.1M | -$252.7M | -$50.63M | $0 | -$137.9M | -$173.7M |
| Investing Cash Flow | $16.19M | -$104.1M | $94.46M | $20.77M | $57.83M | $157.9M | $18.75M | $172.2M |
| Common Stock Issued | $0 | $0 | $12.37M | -- | $0 | $0 | $0 | -$499.3M |
| Financing Cash Flow | $2.59M | $14.98M | $219.0M | $192.1M | -$778K | $1.62M | -$3.76M | -$4.17M |
| Net Change in Cash | -$98.66M | -$186.1M | $182.3M | $114.4M | -$50.24M | $84.26M | -$116.5M | $84.32M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -59.5% | -314.2% | -607.8% | 18.7% | -799.1% | -35.9% | -- | -- |
| Net Profit Margin | -- | -- | -43.9% | -300.6% | -597.2% | 21.2% | -740.7% | -28.1% | -- | -- |
| Return on Equity (ROE) | -50.6% | -34.4% | -14.1% | -31.3% | -30.2% | 6.2% | -50.0% | -6.6% | -18.9% | -- |
| Return on Assets (ROA) | -44.8% | -30.8% | -12.6% | -22.3% | -20.7% | 4.4% | -35.7% | -5.5% | -18.1% | -- |
| Current Ratio | 9.16x | 8.46x | 13.65x | 3.77x | 2.37x | 20.86x | 9.48x | 14.67x | 28.92x | -- |
| Quick Ratio | 9.16x | 8.14x | 13.27x | 3.67x | 2.29x | 20.62x | 9.16x | 14.16x | 28.68x | -- |
| Debt to Equity | 0.04x | 0.04x | 0.05x | 0.06x | 0.07x | 0.06x | 0.18x | -- | -- | -- |
| Revenue Growth (YoY) | -- | -100.0% | +204.7% | +122.9% | -85.5% | +1158.2% | -79.3% | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -571.6% | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -508.5% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -467.7% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -150.8% | -- | -402.5% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -153.2% | -- | -462.8% | -- | -- | -- |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | +72.5% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -554.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -33.9% | -61.2% | -54.9% | -50.6% | -53.8% | -46.6% | -40.4% | -34.4% |
| Return on Assets (ROA) | -25.0% | -44.2% | -40.1% | -44.8% | -47.2% | -41.1% | -35.7% | -30.8% |
| Current Ratio | 6.21x | 8.37x | 9.28x | 9.16x | 9.79x | 10.27x | 9.56x | 8.46x |
| Quick Ratio | 5.94x | 8.32x | 8.97x | 9.16x | 9.41x | 9.87x | 8.90x | 8.14x |
| Debt to Equity | 0.04x | 0.05x | 0.04x | 0.04x | 0.05x | 0.05x | 0.05x | 0.04x |